首页> 外国专利> Synthesis of telaprevir and boceprevir, or pharmaceutically acceptable salts or solvates as well as intermediate products thereof including β-amino acids prepared via Mukaiyama aldol addition

Synthesis of telaprevir and boceprevir, or pharmaceutically acceptable salts or solvates as well as intermediate products thereof including β-amino acids prepared via Mukaiyama aldol addition

机译:telaprevir和boceprevir或其药学上可接受的盐或溶剂化物及其中间产物的合成,包括通过Mukaiyama aldol加成制备的β-氨基酸

摘要

The invention relates to synthetic routes for preparing telaprevir and boceprevir, and its intermediates as well as peptides other than telaprevir. The synthetic routes are based on a Mukaiyama aldol addition reaction of a silyl enol ether or an enolate with an imine. The invention also refers to novel intermediates for preparing telaprevir/boceprevir or other peptides.
机译:本发明涉及制备特拉普拉韦和博西泼韦的合成路线,及其中间体和特拉普拉韦以外的肽。合成路线基于甲硅烷基烯醇醚或烯醇化物与亚胺的Mukaiyama aldol加成反应。本发明还涉及用于制备telaprevir / boceprevir或其他肽的新型中间体。

著录项

  • 公开/公告号US9346853B2

    专利类型

  • 公开/公告日2016-05-24

    原文格式PDF

  • 申请/专利权人 SANDOZ AG;

    申请/专利号US201314408465

  • 申请日2013-06-19

  • 分类号A61K38/04;C07K5/00;C07K7/00;C07K16/00;C07K17/00;C07K5/107;C07D403/12;C07K5/087;C07K5/083;C07K5/062;C07C227/02;C07C231/02;C07C231/12;C07C237/06;C07F7/18;C07K1/10;A61K38/00;

  • 国家 US

  • 入库时间 2022-08-21 14:30:59

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号